Osteoprotegerin (OPG) inhibits the development of osteolytic bone disease in the 5T2MM model of multiple myeloma.

Bibliographic Details
Main Authors:	Croucher, P, Shipman, C, Perry, M, Lippitt, J, Asosingh, K, van Beek, E, Van Camp, B, Russell, G, Dunstan, C, Vanderkerken, K
Format:	Journal article
Published:	2000

Similar Items